Cinacalcet clinical trials
Also written Sensipar and AMG 073.
How each study uses Cinacalcet is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 8 Mar 2004 · SENSIPAR · NDA 021688 (FDA, Drugs@FDA)
- European Union
- 22 Oct 2004 · Mimpara · EMEA/H/C/000570 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
57 studies that test it; most in 2010 (8)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 1999 | 1 |
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 8 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 33 · Other 25
Amgen (30) · Children's Mercy Hospital Kansas City (2) · Seoul National University Hospital (2) · Montefiore Medical Center (2) · VA Office of Research and Development (1) · University Hospital, Rouen (1) · Karolinska University Hospital (1) · Kyowa Kirin China Pharmaceutical Co., Ltd. (1)
Often tested with
Tested in the same studies.
Alendronate (1) · Teriparatide (1) · Denosumab (1) · Paricalcitol (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Cinacalcet is the comparator. A study of two new drugs counts under both.
- 1MT1013 · Shaanxi Micot Pharmaceutical Technology Co., Ltd. · next primary completion Nov 2026
Studies
Open first, then newest update. How each study uses Cinacalcet is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 58
- Novel Combination Therapy for Osteoporosis in MenCompletedPhase 4VA Office of Research and DevelopmentNCT03994172Written as Cinacalcet
- Evaluation of a Cincalcet Suppression TestCompletedPhase 4University Hospital, RouenNCT01103206Written as cinacalcet
- Cinacalcet to Treat Hypercalcemia in Renal Transplant RecipientsTerminatedPhase 1/2Montefiore Medical CenterNCT00415584Written as Cinacalcet HCl
- Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?CompletedNot applicableKarolinska University HospitalNCT02227264Written as Cinacalcet
- Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPTCompletedPhase 4Kyowa Kirin China Pharmaceutical Co., Ltd.NCT03123406Written as Cinacalcet HCl
- Parathyroid Hormone Level and Growth in Pediatric Patients With ESRD on Regular HemodialysisCompletedPhase 4Tanta UniversityNCT05926570Written as Cinacalcet
- Renal Osteodystrophy: An Individual Management ApproachCompletedNot applicableHartmut Malluche, MDNCT02440581Written as Cinacalcet
- E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular EventsCompletedPhase 3AmgenNCT00345839Written as Cinacalcet
- Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis PatientsCompletedPhase 4The University of Hong KongNCT01447368Written as Cinacalcet
- Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.CompletedPhase 3Peter VestergaardNCT03027557Written as Cinacalcet 30 mg Tablet
- Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney TransplantTerminatedNot applicableMontefiore Medical CenterNCT01011114Written as Cinacalcet
- Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic RicketsCompletedPhase 1Children's Mercy Hospital Kansas CityNCT00195936Written as Cinacalcet
- Calcimimetics in Hypophosphatemic RicketsWithdrawnNot applicableChildren's Mercy Hospital Kansas CityNCT00844740Written as Cinacalcet
- Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet TreatmentCompletedNot applicableMin-Sheng General HospitalNCT04637360Written as Cinacalcet Tablets
- Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on DialysisCompletedPhase 3AmgenNCT02341417Written as Cinacalcet
- Pediatric Chronic Kidney Disease Safety and EfficacyTerminatedPhase 3AmgenNCT01277510Written as cinacalcet capsule
- Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on DialysisTerminatedPhase 3AmgenNCT02138838Written as Cinacalcet HCl
- Study to Evaluate Cinacalcet in Children With Chronic Kidney DiseaseCompletedPhase 1AmgenNCT01290029Written as Cinacalcet
- Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary HyperparathyroidismTerminatedPhase 2AmgenNCT01439867Written as Cinacalcet hydrochloride
- Interaction Between a Calcimimetic Agent and the Renin Angiotensine Aldosterone SystemCompletedNot applicableCentre Hospitalier Universitaire VaudoisNCT01519037Written as Cinacalcet 60 MG
See all 58 studies that test Cinacalcet →
Given beside what is tested · 2 — Cinacalcet is usual care or a partner of the new treatment
- Evaluating Alternative Medical Therapies in Primary HyperparathyroidismCompletedPhase 2/3Brigham and Women's HospitalNCT02525796Written as Cinacalcet
- Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed PatientsTerminatedPhase 3Centre Hospitalier Universitaire, AmiensNCT01011699Written as cinacalcet
As the comparator · 9 — what is tested is compared with Cinacalcet
- Study of MT1013 for the Treatment of Patients With Secondary HyperparathyroidismRecruitingPhase 3Shaanxi Micot Pharmaceutical Technology Co., Ltd.NCT07122401Written as Cinacalcet
- A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing HemodialysisCompletedPhase 2Astellas Pharma IncNCT02133404Written as Cinacalcet
- A Study of SHR6508 in Secondary HyperparathyroidismStatus unknownPhase 2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT05663411Written as Cinacalcet
- Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in AsiaCompletedPhase 3Kyowa Kirin Co., Ltd.NCT03822507Written as Cinacalcet Hydrochloride
- Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)CompletedPhase 3AmgenNCT03299244Written as Cinacalcet
- Head-to-Head Study of Etelcalcetide (AMG 416) and CinacalcetCompletedPhase 3AmgenNCT01896232Written as Cinacalcet
- Phase 2 Study of KHK7580CompletedPhase 2Kyowa Kirin Co., Ltd.NCT02216656Written as KRN1493
- Phase 3 Study of KHK7580CompletedPhase 2/3Kyowa Kirin Co., Ltd.NCT02549391Written as KRN1493
- ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving HemodialysisCompletedPhase 4AmgenNCT00379899Written as cinacalcet
Codes
What other systems call Cinacalcet · ClinicalTrials.gg INT006583
- MeSH (NLM) D000069449CinacalcetConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) UAZ6V7728SCINACALCETConfirmed FDA, NLM, Wikidata
- RxNorm 407990Confirmed FDA, Wikidata
- Wikidata Q193978cinacalcetConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C74100CinacalcetOne source FDA
- DrugBank DB01012One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069449 | Cinacalcet | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | UAZ6V7728S | CINACALCET | Confirmed FDA, NLM, Wikidata |
| RxNorm | 407990 | — | Confirmed FDA, Wikidata |
| Wikidata | Q193978 | cinacalcet | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C74100 | Cinacalcet | One source FDA |
| DrugBank | DB01012 | — | One source Wikidata |
Also registered as cinacalcet hydrochloride (UNII 1K860WSG25 · RxNorm 384379).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.